ITC on Thursday confirmed that it is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials. The company will reportedly market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals. An ITC spokesperson told PTI, "We are unable to share more details...as...trials are underway." The stock jumped nearly 2%.
top of page
bottom of page